These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 3315450

  • 21. Guanfacine: a new centrally-acting antihypertensive agent.
    Beevers DG, Bloxham CA, Walker JM.
    Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
    [Abstract] [Full Text] [Related]

  • 22. [Hypotensive and hemodynamic effects of guanfacine in arterial hypertension].
    Erina EV, Beliakova EV, Charyev KhZ, Panfilov VV.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(1):63-7. PubMed ID: 2663029
    [Abstract] [Full Text] [Related]

  • 23. Long-term efficacy and tolerance of the antihypertensive agent guanfacine.
    Jerie P, Lasance A.
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):170-4. PubMed ID: 6370876
    [Abstract] [Full Text] [Related]

  • 24. Antihypertensive treatment in mild hypertension, its problems and future trends.
    Widimský J.
    Cor Vasa; 1987 Mar; 29(4 Suppl 1):1-10. PubMed ID: 3315445
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
    Magometschnigg D, Bonelli J, Hitzenberger G, Kaik G.
    Arzneimittelforschung; 1980 Mar; 30(6):1005-7. PubMed ID: 6998487
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)].
    Rosenthal J, Schäfer N, Rauh J, Raschig A.
    Dtsch Med Wochenschr; 1980 Nov 28; 105(48):1680-4. PubMed ID: 7002524
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Clinical pharmacology of the antihypertensive action of guanfacine].
    Safar M, Weiss Y, Georges D.
    Arch Mal Coeur Vaiss; 1980 Oct 28; 73(10):1171-7. PubMed ID: 6778409
    [Abstract] [Full Text] [Related]

  • 36. [First experiences with BS 100-141, a new antihypertensive substance].
    Esch I.
    Int J Clin Pharmacol Biopharm; 1976 Sep 28; 14(2):109-12. PubMed ID: 793999
    [Abstract] [Full Text] [Related]

  • 37. Effect of guanfacine on blood pressure and renin activity in hypertensive patients.
    Rosenthal J.
    Br J Clin Pharmacol; 1980 Sep 28; 10 Suppl 1(Suppl 1):91S-96S. PubMed ID: 6994787
    [Abstract] [Full Text] [Related]

  • 38. Improved glucose tolerance after guanfacine treatment in hypertensive diabetic (type II) patients: one year follow up.
    Hauger-Klevene JH, Scornavacchi JC.
    Horm Metab Res; 1985 Nov 28; 17(11):613-4. PubMed ID: 3908271
    [No Abstract] [Full Text] [Related]

  • 39. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
    Rhomberg F, Widler J.
    Schweiz Med Wochenschr; 1981 Dec 12; 111(50):1967-8. PubMed ID: 7036334
    [Abstract] [Full Text] [Related]

  • 40. Guanfacine for hypertension.
    Med Lett Drugs Ther; 1987 May 22; 29(740):49-50. PubMed ID: 2883560
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.